Portal:COVID-19/FeaturedPathways
From WikiPathways
(→SARS-CoV-2 Pathways) |
|||
Line 5: | Line 5: | ||
Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. | Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. | ||
|width=100px|{{#pwImage:Pathway:WP4860|250px||Hijack of Ubiquitination by SARS-CoV-2}} | |width=100px|{{#pwImage:Pathway:WP4860|250px||Hijack of Ubiquitination by SARS-CoV-2}} | ||
- | SARS-CoV-2 includes a novel Orf10 that interacts with | + | SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
|width=100px|{{#pwImage:Pathway:WP4868|250px||Type I Interferon Induction and Signaling During SARS-CoV-2 Infection}} | |width=100px|{{#pwImage:Pathway:WP4868|250px||Type I Interferon Induction and Signaling During SARS-CoV-2 Infection}} | ||
The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. | The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. | ||
Line 52: | Line 52: | ||
|- | |- | ||
|} | |} | ||
+ | |||
+ | List of featured pathways: | ||
+ | * [[Pathway:WP4846]] | ||
+ | * [[Pathway:WP4860]] | ||
+ | * [[Pathway:WP4868]] | ||
+ | * [[Pathway:WP4927]] | ||
+ | |||
+ | * [[Pathway:WP4010]] | ||
+ | * [[Pathway:WP4011]] | ||
+ | * [[Pathway:WP4017]] | ||
+ | * [[Pathway:WP4026]] | ||
+ | * [[Pathway:WP2643]] | ||
+ | * [[Pathway:WP2507]] | ||
+ | * [[Pathway:WP2513]] | ||
+ | * [[Pathway:WP2509]] | ||
+ | * [[Pathway:WP3287]] | ||
+ | * [[Pathway:WP3890]] | ||
+ | * [[Pathway:WP3181]] | ||
+ | * [[Pathway:WP4891]] | ||
+ | * [[Pathway:WP4914]] | ||
+ | * [[Pathway:WP4944]] | ||
+ | * [[Pathway:WP4945]] |
Revision as of 19:55, 9 September 2020
SARS-CoV-2 Pathways
Image does not exist Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist |
Image does not exist |
Other coronaviruses: MERS, SARS-CoV, etc
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |
List of featured pathways: